Abstract:Objective To investigate the effect of stratified blood pressure control on cognitive dysfunction in patients with cerebral small vessel disease.Methods Fifty-six patients with cerebral small vessel disease complicated with hypertension admitted to Peking University First Hospital between October 2013 and January 2015 were randomly divided into enhanced anti-hypertension group (target systolic pressure 100-129 mmHg) and standard anti-hypertension group(target systolic pressure 130-139 mmHg).Antihypertensive drugs and doses were adjusted to achieve the target blood pressure.All patients were followed for 2 years.Cognitive function was assessed by Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA).Lacunar infarction(LI) and white matter lesion(WML) were observed by cranial magnetic resonance imaging.Results After 2-year follow-up,20 patients in enhanced anti-hypertension group reached the target blood pressure;in standard anti-hypertension group(26 patients),17 patients reached the target blood pressure(130-139 mmHg,standard anti-hypertension group 1) and 9 patients reached 100-129 mmHg(standard anti-hypertension group 2).MMSE and MoCA scores showed no significant changes in enhanced anti-hypertension group and standard anti-hypertension group 2(P ＞ 0.05);MMSE and MoCA scores in standard anti-hypertension group 1 were significantly lower than those before treatment [(26.9 ± 2.8) vs (27.5 ± 2.2),(22.4 ± 3.4) vs (23.4 ± 3.9)] (both P ＜ 0.05).There was no significant change of LI score in enhanced anti-hypertension group and standard anti-hypertension group 1,2;WML score in enhanced anti-hypertension group and standard anti-hypertension group 2 showed no significant change;WML score after 2-year follow-up in standard anti-hypertension group 1 was significantly higher than that before treatment[(5.0 ± 1.6) vs (4.8 ± 1.4)] (P =0.02).Multivariate logistic regression showed that WML score(odds ratio =3.38,95％ confidence interval:3.12-8.41,P =0.008),age(odds ratio =2.95,95％ confidence interval:2.72-6.08,P =0.028),systolic blood pressure (odds ratio =1.89,95％ confidence interval:1.68-5.46,P =0.026) and LI score(odds ratio =1.84,95％ confidence interval:1.61-8.20,P =0.025) were influence factors of MMSE score.Conclusion Enhanced blood pressure control can delay the cognitive impairment in patients with cerebral small vessel disease.

Effect of stratified blood pressure control on cognitive dysfunction in patients with cerebral small vessel disease